Clinical Trial Update: Efficacy and Safety of TAK-379 in Adult Subjects With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the efficacy and safety of TAK-379 in adults with type 2 diabetes mellitus; the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• TAK-379

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus | Phase 2 | Status: TERMINATED